|
業務類別
|
Drug Manufacturers - Specialty & Generic |
|
業務概覽
|
Organogenesis Holdings Inc is a regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the advanced wound care, surgical, and sports medicine markets. The company's portfolio of regenerative medicine products in the advanced wound care category includes Apligraf, Dermagraft, PuraPly AM, CYGNUS Dual, etc., and the sports medicine products include NuShield as a surgical barrier and PuraForce as a reinforcement matrix in targeted soft tissue repairs; and Affinity, Novachor, PuraPly MZ, PuraPly AM, and PuraPly SX for management of open wounds in the surgical setting. The company operates in a single segment, that is, regenerative medicine. |
| 公司地址
| 85 Dan Road, Canton, MA, USA, 02021 |
| 電話號碼
| +1 781 575-0775 |
| 傳真號碼
| +1 781 575-1570 |
| 公司網頁
| https://www.organogenesis.com |
| 員工數量
| 854 |
| Ms. Lori Freedman |
Chief Administrative and Legal Officer |
美元 499.38K |
12/05/2025 |
| Mr. Robert Cavorsi |
Vice President, Strategy |
-- |
12/05/2025 |
| Mr. Patrick McGuire |
Chief Accounting Officer |
-- |
23/02/2026 |
| Mr. David C. Francisco |
Chief Financial Officer |
美元 469.27K |
23/02/2026 |
| Mr. Gary S. Gillheeney, Sr |
Chairman of the Board, President and Chief Executive Officer |
美元 942.51K |
26/02/2026 |
| Mr. Patrick Bilbo |
Chief Operating Officer |
美元 489.30K |
12/05/2025 |
| Mr. Brian Grow |
Chief Commercial Officer |
美元 463.80K |
12/05/2025 |
| Mr. Antonio S. Montecalvo |
Vice President, Health Policy |
-- |
12/05/2025 |
|
|
| Mr. Glenn H. Nussdorf |
Director |
26/02/2026 |
| Mr. Garrett Lustig |
Independent Director |
26/02/2026 |
| Mr. Gilberto Quintero |
Independent Director |
26/02/2026 |
| Dr. Michael Joseph Driscoll |
Independent Director |
26/02/2026 |
| Mr. David Erani |
Director |
12/05/2025 |
| Mr. Robert Ades |
Director |
26/02/2026 |
| Mr. Gary S. Gillheeney, Sr |
Chairman of the Board, President and Chief Executive Officer |
26/02/2026 |
| Mr. Alan A. Ades |
Director |
12/05/2025 |
| Ms. Prathyusha Duraibabu |
Independent Director |
26/02/2026 |
| Ms. Michele Korfin |
Independent Director |
26/02/2026 |
| Mr. Jon L. Giacomin |
Independent Director |
26/02/2026 |
| Mr. Arthur S. Leibowitz |
Lead Independent Director |
26/02/2026 |
|
|
|
|
